Detalhe da pesquisa
1.
The Beneluxa Initiative domain task force health technology assessment: a comparison of member countries' past health technology assessments.
Int J Technol Assess Health Care
; 39(1): e44, 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37317832
2.
Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements.
Int J Technol Assess Health Care
; 37(1): e83, 2021 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424152
3.
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines.
Br J Clin Pharmacol
; 86(6): 1034-1051, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162368
4.
The impact of parallel regulatory-health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations.
Br J Clin Pharmacol
; 84(5): 1013-1019, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370449
5.
How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory-HTA parallel scientific advice.
Br J Clin Pharmacol
; 82(4): 965-73, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27245362
6.
Standardized reporting for rapid relative effectiveness assessments of pharmaceuticals.
Int J Technol Assess Health Care
; 30(5): 488-96, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25747557
7.
Piloting international production of rapid relative effectiveness assessments of pharmaceuticals.
Int J Technol Assess Health Care
; 30(5): 521-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25747562
8.
Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years' multi-stakeholder dialogue on improving access in Europe via MoCA.
Orphanet J Rare Dis
; 18(1): 144, 2023 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308991
9.
The use of national reimbursement reports to support formulary decisions of the hospital's Drug and Therapeutics Committee: a comparative analysis.
Int J Clin Pharm
; 44(3): 769-774, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35199288
10.
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.
Front Pharmacol
; 8: 497, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28878667
11.
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.
Front Pharmacol
; 7: 305, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27733828
12.
Low NO bioavailability in CCl4 cirrhotic rat livers might result from low NO synthesis combined with decreased superoxide dismutase activity allowing superoxide-mediated NO breakdown: A comparison of two portal hypertensive rat models with healthy controls.
Comp Hepatol
; 2(1): 2, 2003 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-12575897
13.
Pdx1- and Ngn3-Cre-mediated PLAG1 expression in the pancreas leads to endocrine hormone imbalances that affect glucose metabolism.
Cell Transplant
; 20(8): 1285-97, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21294959
14.
A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis.
Hepatology
; 42(6): 1382-90, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16317694
15.
Halofuginone can worsen liver fibrosis in bile duct obstructed rats.
Liver Int
; 24(5): 502-9, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15482349